Proteus has prematurely ended its high profile $88 million deal with Otsuka, reports MobiHealthNews. Proteus’ CEO, Andrew Thompson, told STAT News that the company...
Otsuka Pharmaceutical Co., Ltd. and Proteus Digital Health has agreed to expand global collaboration for the further development and commercialization of a portfolio of...
Otsuka Pharmaceuticals announced that it has signed a Collaboration Agreement with health management group Magellan Health to distribute its drug-device combo Abilify Mycite in...